Caucasian patients with insulin-dependent diabetes mellitus and normoalbuminuria (83% in DD, 87% in DI and 81% in II) at baseline showed comparable treatment effects from ACE inhibitors between genotypes within the first 12 months. This evidence concerns the gene ACE and diabetes mellitus.